Somewhat Positive Media Coverage Somewhat Unlikely to Affect Medical Transcription Billing (MTBC) Share Price

Media headlines about Medical Transcription Billing (NASDAQ:MTBC) have trended somewhat positive on Tuesday, Accern reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medical Transcription Billing earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the technology company an impact score of 47.3935082804094 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Medical Transcription Billing (NASDAQ:MTBC) traded up $0.08 during midday trading on Tuesday, hitting $3.48. The company had a trading volume of 223,100 shares, compared to its average volume of 606,058. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.01. Medical Transcription Billing has a one year low of $0.29 and a one year high of $5.44. The company has a market capitalization of $39.20, a price-to-earnings ratio of -3.31 and a beta of 1.98.

MTBC has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Medical Transcription Billing from a “hold” rating to a “buy” rating and set a $3.00 price objective on the stock in a research report on Wednesday, December 27th. Chardan Capital lifted their price objective on Medical Transcription Billing from $2.25 to $2.75 and gave the stock a “buy” rating in a research report on Tuesday, November 14th. Finally, ValuEngine lowered Medical Transcription Billing from a “hold” rating to a “sell” rating in a research report on Monday, December 4th.

In other news, CEO Mahmud Ul Haq purchased 30,000 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were bought at an average cost of $2.93 per share, for a total transaction of $87,900.00. Following the completion of the transaction, the chief executive officer now directly owns 5,017,070 shares of the company’s stock, valued at approximately $14,700,015.10. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 53.70% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/13/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-medical-transcription-billing-mtbc-share-price.html.

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply